SC
MDT icon

Swan Capital’s Medtronic MDT Stock Holding History

Swan Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27K Hold
29
– – ﹤0.01% 352
2026
Q1 		$2.51K Hold
29
– – ﹤0.01% 330
2025
Q4 		$2.79K Sell
29
-86
-75% -$8.35K ﹤0.01% 293
2025
Q3 		$11K Buy
115
+29
+34% +$2.67K ﹤0.01% 157
2025
Q2 		$7.5K Hold
86
– – ﹤0.01% 188
2025
Q1 		$7.73K Sell
86
-27
-24% -$2.42K ﹤0.01% 159
2024
Q4 		$9.03K Buy
113
+17
+18% +$1.47K ﹤0.01% 138
2024
Q3 		$8.64K Sell
96
-270
-74% -$22.7K ﹤0.01% 145
2024
Q2 		$28.8K Buy
+366
New +$30K 0.02% 88

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swan Capital's MDT Position: Q2 2026 in Review

Swan Capital held its Medtronic (MDT) position steady in Q2 2026 at 29 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #352.

Swan Capital first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $28.8K in Q2 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Swan Capital held 29 shares of Medtronic worth $2.27K as of Q2 2026.
  • Swan Capital left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #352 holding.
  • Swan Capital first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Swan Capital's Medtronic position peaked at $28.8K in Q2 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.